Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001)
Cancer Chemotherapy and Pharmacology · 2024
DOI: 10.1007/s00280-024-04648-6 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Mayumi Ozawa und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-00…. Hauptthemen laut MEDLINE: Oxaliplatin, Tegafur, Oxonic Acid, Colorectal Neoplasms. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
- Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, 4-57, Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan. nabe-jun@comet.ocn.ne.jp.
- Department of Surgery, National Hospital Organization Yokohama Medical Center, Yokohama, Kanagawa, Japan.
- Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, 4-57, Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.
- Department of Surgery, Yokosuka Kyosai Hospital, Yokosuka, Kanagawa, Japan.
- Department of Surgery, Yokohama City Minato Red Cross Hospital, Yokohama, Kanagawa, Japan.
ORCID-Profile: Jun Watanabe
Zitieren
APA
Ozawa, M., Watanabe, J., Ishibe, A., Goto, K., Fujii, Y., Nakagawa, K., Suwa, Y., Suwa, H., Masui, H., Sugita, M., Mochizuki, Y., Yamagishi, S., Hasegawa, S., Homma, Y., Momiyama, M., Kumamoto, T., Matsuyama, R., Takeda, K., Taguri, M., & Endo, I. (2024). Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001). Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04648-6
Vancouver
Ozawa M, Watanabe J, Ishibe A, Goto K, Fujii Y, Nakagawa K, et al. Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001). Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04648-6
BibTeX
@article{Ozawa2024,
author = {Ozawa, Mayumi and Watanabe, Jun and Ishibe, Atsushi and Goto, Koki and Fujii, Yoshiro and Nakagawa, Kazuya and Suwa, Yusuke and Suwa, Hirokazu and Masui, Hidenobu and Sugita, Mitsutaka and Mochizuki, Yasuhisa and Yamagishi, Shigeru and Hasegawa, Seiji and Homma, Yuki and Momiyama, Masashi and Kumamoto, Takafumi and Matsuyama, Ryusei and Takeda, Kazuhisa and Taguri, Masataka and Endo, Itaru},
title = {Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001)},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2024},
doi = {10.1007/s00280-024-04648-6}
}
EUVIMED